Cibc World Market Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Cibc World Market Inc.

  • $48 Billion
  • Q3 2024

A detailed history of Cibc World Market Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 1,324 shares of REGN stock, worth $943,217. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,324
Previous 1,368 3.22%
Holding current value
$943,217
Previous $1.44 Million 3.2%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$1024.09 - $1201.76 $45,059 - $52,877
-44 Reduced 3.22%
1,324 $1.39 Million
Q2 2024

Aug 07, 2024
BUY
$883.2 - $1071.19 $186,355 - $226,021
211 Added 18.24%
1,368 $1.44 Million
Q1 2024

May 13, 2024
SELL
$902.69 - $993.35 $7,221 - $7,946
-8 Reduced 0.69%
1,157 $1.11 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $15,503 - $17,634
20 Added 1.75%
1,165 $1.02 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $125,333 - $152,830
181 Added 18.78%
1,145 $942,000
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $814,134 - $965,697
-1,163 Reduced 54.68%
964 $693,000
Q1 2023

May 12, 2023
SELL
$680.49 - $826.97 $210,271 - $255,533
-309 Reduced 12.68%
2,127 $1.75 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $195,531 - $212,290
277 Added 12.83%
2,436 $1.76 Million
Q3 2022

Nov 10, 2022
SELL
$573.97 - $724.32 $1.68 Million - $2.12 Million
-2,922 Reduced 57.51%
2,159 $1.49 Million
Q2 2022

Aug 10, 2022
SELL
$548.35 - $738.84 $732,047 - $986,351
-1,335 Reduced 20.81%
5,081 $3 Million
Q1 2022

May 12, 2022
BUY
$595.12 - $698.43 $51,180 - $60,064
86 Added 1.36%
6,416 $4.48 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $925,546 - $1.14 Million
-1,703 Reduced 21.2%
6,330 $4 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $2.05 Million - $2.43 Million
3,563 Added 79.71%
8,033 $4.86 Million
Q2 2021

Aug 12, 2021
BUY
$472.8 - $558.54 $511,569 - $604,340
1,082 Added 31.94%
4,470 $2.5 Million
Q1 2021

May 11, 2021
SELL
$446.73 - $548.2 $197,007 - $241,756
-441 Reduced 11.52%
3,388 $1.6 Million
Q4 2020

Feb 08, 2021
BUY
$478.3 - $607.98 $337,201 - $428,625
705 Added 22.57%
3,829 $1.85 Million
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $5.14 Million - $6.21 Million
-9,430 Reduced 75.12%
3,124 $1.75 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $4.73 Million - $6.17 Million
9,584 Added 322.69%
12,554 $7.83 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $2.32 Million - $3.41 Million
-6,893 Reduced 69.89%
2,970 $1.45 Million
Q4 2019

Feb 13, 2020
BUY
$274.13 - $376.51 $1.79 Million - $2.45 Million
6,519 Added 194.95%
9,863 $3.7 Million
Q3 2019

Nov 13, 2019
BUY
$273.46 - $318.39 $305,728 - $355,960
1,118 Added 50.22%
3,344 $928,000
Q2 2019

Aug 08, 2019
BUY
$299.6 - $414.82 $666,909 - $923,389
2,226 New
2,226 $697,000
Q1 2019

May 09, 2019
SELL
$372.08 - $439.57 $241,107 - $284,841
-648 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $2.79 Million - $3.35 Million
-8,320 Reduced 92.77%
648 $242,000
Q3 2018

Nov 09, 2018
BUY
$351.14 - $408.51 $2.04 Million - $2.37 Million
5,802 Added 183.26%
8,968 $3.62 Million
Q2 2018

Aug 08, 2018
BUY
$284.6 - $344.99 $308,791 - $374,314
1,085 Added 52.14%
3,166 $1.09 Million
Q1 2018

May 18, 2018
BUY
$315.82 - $393.78 $153,172 - $190,983
485 Added 30.39%
2,081 $717,000
Q4 2017

Feb 01, 2018
BUY
$358.63 - $469.95 $296,945 - $389,118
828 Added 107.81%
1,596 $600,000
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $331,299 - $387,072
768
768 $343,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email